Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Naproxcinod

EU orphan designation number: EU/3/13/1194   
Active ingredient: Naproxcinod
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: NicOx
Drakkar 2- Bat D, 2405 route des Dolines, CS 10313 Sophia Antipolis, 06560 Valbonne, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2013 Centralised Orphan - Designation EMA/OD/090/13 (2013)6739 of 07/10/2013